Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Economic analysis of using home mechanical ventilation for children with neuromuscular weakness: the case study from Thailand.

Respiratory medicine·2026
Same author

Preventive and therapeutic efficacy of mRNA/LNP vaccines encoding HPV16 E6 and E7 in an early-intervention HPV tumor mouse models.

Human vaccines & immunotherapeutics·2026
Same author

Developing and implementing an MSM-led, community-based HIV service model in South Sulawesi: an implementation research process evaluation.

JBI evidence implementation·2026
Same author

Chronic Obstructive Pulmonary Disease and Asthma Among Workers and Residents of Navanakorn Industrial Zone, Thailand.

Medical sciences (Basel, Switzerland)·2026
Same author

Client-centered enablers and persistent bottlenecks across Indonesia's HIV cascade: a multi-stakeholder qualitative study.

AIDS care·2026
Same author

Obstructive Sleep Apnea Diagnosis and Management During Pregnancy.

Sleep medicine clinics·2026

相关实验视频

Updated: Sep 8, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

喘缓解:治愈的途径?

Chirawat Chiewchalermsri1, Dichapong Kanjanawasee2,3, Narongkorn Saiphoklang4

  • 1Department of Medicine, Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Nonthaburi, Thailand.

Asian Pacific journal of allergy and immunology
|July 13, 2025
PubMed
概括

实现喘缓解,定义为持续缺乏症状和恶化,是一个可行的目标. 整体护理,包括管理过敏呼吸道疾病和生活方式因素,显著支持缓解.

更多相关视频

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.8K

相关实验视频

Last Updated: Sep 8, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.8K

科学领域:

  • 肺部病理学 肺部病理学
  • 过敏学 过敏学
  • 临床医学 临床医学

背景情况:

  • 喘是一种慢性炎症性呼吸道疾病,症状变化和空气流量限制.
  • 目前的治疗方法提供了控制,但不是最终的治疗方法,使得缓解成为一个关键的管理目标.

研究的目的:

  • 审查当前对喘缓解率和影响因素的理解.
  • 评估各种治疗策略对实现喘缓解的影响.
  • 强调综合性护理对喘管理的重要性.

主要方法:

  • 文献综述总结了关于喘缓解的最新发现.
  • 分析治疗策略,包括免疫疗法和生物药物.
  • 综合性喘护理组件的评估.

主要成果:

  • 临床缓解是喘管理中可以实现的目标.
  • 影响缓解的因素包括免疫疗法,生物药物和综合护理.
  • 整体方法,如治疗并发性过敏症和改变生活方式至关重要.

结论:

  • 虽然喘的治愈仍然难以捉摸,但临床缓解是可以实现的.
  • 对过敏性气道疾病的综合管理和生活方式的调整对于改善喘控制和实现缓解至关重要.
  • 需要进一步的研究来探索喘治愈的可能性.